novo nordisk patent semaglutide Ozempic's problem: how lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Whoops! novonordisk will lose its

Changes are communicated, not discovered on the next refill

This suggests the medication may have been frozen at some point

Moreover, bananas have an odd genetic makeup: they are triploids, with three sets of chromosomes, making them inherently sterile

With anti-A and anti-tau therapies entering AD practice, GLP-1RAs may be most effective in combination, targeting metabolic and inflammatory pathways that complement direct amyloid or tau lowering

Physiological Hyperglycemia Slows Gastric Emptying in Normal Subjects and Patients with Insulin-Dependent Diabetes Mellitus

While the study only examines a single patient, it offers at least a glimpse of relief for others living with a condition that currently has no known cure